Idera Pharmaceuticals, Inc. (IDRA) Reports Third Quarter 2013 Financial Results And Provides Corporate Update
11/14/2013 9:28:04 AM
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune diseases and genetically defined forms of B-cell lymphoma, today reported financial results for the quarter ended September 30, 2013 and provided a corporate update.
Help employers find you! Check out all the jobs and post your resume.